Nitric Oxide Deficit Drives Intimal Hyperplasia in Mouse Models of Hypertension

Area of Science:

• Vascular Biology
• Cardiovascular Research
• Hypertension Pathophysiology

Background:

• Intimal hyperplasia (IH) is a key feature in vascular disease.
• Hypertension is a known risk factor for IH development.
• Different mechanisms of hypertension may differentially affect IH.

Purpose of the Study:

• To investigate the impact of various hypertension models on intimal hyperplasia (IH) development.
• To compare IH formation in response to renin-independent and renin-dependent hypertension.
• To elucidate the role of nitric oxide (NO) deficiency in hypertension-induced IH.

Main Methods:

• Utilized murine models of carotid artery ligation (CAL) in normotensive and hypertensive mice (L-NAME, 2K1C, Cx40-/-).
• Induced hypertension via pharmacological (L-NAME), surgical (2K1C), and genetic (Cx40-/-) methods.
• Assessed blood pressure, morphometrics, and histology of ligated carotids at multiple time points post-CAL.

Main Results:

• Carotid artery ligation (CAL) induced significant intimal hyperplasia (IH) in all hypertensive groups compared to normotensive controls.
• L-NAME induced hypertension, characterized by nitric oxide (NO) deficiency, resulted in more severe IH than other models.
• L-NAME treatment led to increased vascular smooth muscle cell (VSMC) proliferation and inflammatory cell infiltration.

Conclusions:

• Nitric oxide (NO) deficiency plays a critical role in promoting vascular inflammation, VSMC proliferation, and intimal hyperplasia (IH) under hypertensive conditions.
• The specific type of hypertension influences the extent of IH development.
• Targeting NO pathways may be crucial for managing IH in hypertensive patients.